Literature DB >> 1867736

Baseline corrections in experimental and quasi-experimental clinical trials.

J E Overall1, B Ashby.   

Abstract

Three methods of correcting for baseline differences are evaluated for use with randomized experimental designs and nonrandomized quasi-experimental designs. Cases where baseline means differ significantly in spite of random assignment and cases where observed baseline means do not differ significantly in quasi-experimental designs are given special attention. For comparison of treatment-induced change in randomly constituted treatment groups, analysis of covariance (ANCOVA) provides appropriate type I error protection and superior power regardless of the apparent significance of chance baseline differences. Correcting for baseline differences by expressing outcome scores as percentage of the baseline value for each individual produces results that closely approximate ANCOVA under specified conditions. Tests on simple pre-post difference scores are nonconservative when baseline means differ significantly in spite of randomization. In quasi-experimental research where treatment groups represent samples from different predefined populations, ANCOVA and percentage change provide inadequate baseline corrections even when the observed baseline means do not differ significantly. Although no method of baseline correction is entirely satisfactory in the absence of random assignment, tests on simple pre-post difference scores are generally superior for quasi-experimental designs in which treatment groups represent samples from different populations.

Mesh:

Substances:

Year:  1991        PMID: 1867736

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  8 in total

1.  Informed consent.

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  1993-04-03

Review 2.  Appetite control: methodological aspects of the evaluation of foods.

Authors:  J Blundell; C de Graaf; T Hulshof; S Jebb; B Livingstone; A Lluch; D Mela; S Salah; E Schuring; H van der Knaap; M Westerterp
Journal:  Obes Rev       Date:  2010-01-29       Impact factor: 9.213

3.  Effects of raclopride treatment on plasma and CSF HVA: relationships with clinical improvement in male schizophrenics.

Authors:  J G Csernansky; J W Newcomer; K Jackson; L Lombrozo; K F Faull; R Zipursky; A Pfefferbaum; W O Faustman
Journal:  Psychopharmacology (Berl)       Date:  1994-11       Impact factor: 4.530

4.  Effect of interventions on stage of mammography adoption.

Authors:  V Champion; G Huster
Journal:  J Behav Med       Date:  1995-04

5.  A randomised controlled trial of a self-management education program for osteoarthritis of the knee delivered by health care professionals.

Authors:  Sophie Coleman; N Kathryn Briffa; Graeme Carroll; Charles Inderjeeth; Nicola Cook; Jean McQuade
Journal:  Arthritis Res Ther       Date:  2012-01-27       Impact factor: 5.156

6.  Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study.

Authors:  Bolaji E Egbewale; Martyn Lewis; Julius Sim
Journal:  BMC Med Res Methodol       Date:  2014-04-09       Impact factor: 4.615

7.  Metastability in plyometric training on unstable surfaces: a pilot study.

Authors:  Claudia Classen; Thomas Muehlbauer; Urs Granacher; David G Behm; Armin Kibele
Journal:  BMC Sports Sci Med Rehabil       Date:  2014-07-17

8.  Unreliable Yet Still Replicable: A Comment on LeBel and Paunonen (2011).

Authors:  Maarten De Schryver; Sean Hughes; Yves Rosseel; Jan De Houwer
Journal:  Front Psychol       Date:  2016-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.